CareersFind a DoctorMake an AppointmentDepartmentsDirections & ParkingGiftsContact UsPRINT

	Neurology   From the Chair   Faculty   Grand Rounds   Presentations   Research   Outpatient Clinic   Neurology Sections   Adult Residency   Pediatric Residency   Fellowships   Neurology in the News		WFUBMC Home   >    Neurology   >    Research   >    Ovation - Psychosis in Parkinson's Patients OVATION- Psychosis in Parkinson’s Patients Principal Investigator:  Allison Brashear, MD Objective:  Assess the safety and effectiveness of 20mg, 40mg, and 60mg per day of melperone syrup in subjects with psychosis associated with Parkinson’ disease. Therpay:  Melperone syrup (5mg/ml) Inclusion/Exclusion Criteria: Clinical diagnosis of Parkinson’s Disease Diagnosis with psychosis (hallucinations, delusions) No history of significant psychotic disorders prior to Parkinson’s disease Contact: Emily Smith              336 716-2133              emsmith@wfubmc.edu Sponsor:  Ovation Pharmaceuticals Pending

[Website Access Agreement] [Privacy Notices] [Copyright Information] [Campus Security Act]
Copyright: Wake Forest University School of Medicine and North Carolina Baptist Hospitals. All rights reserved.
Medical Center Boulevard
Winston-Salem, NC 27157
The information on this Website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. If you have a medical problem or a health-related question, consult your physician or call Health On-Call at 336-716-2255 or 1-800-446-2255.
Send Feedback	Home	Site Index
	Last Modified: 3/6/2007